Advances in the understanding of acquired haemophilia A: Implications for clinical practice

British Journal of Haematology

Volumn 148, Issue 2, 2010, Pages 183-194

  Collins, Peter W ^a   Percy, Charles L ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Acquired haemophilia; Bypassing agents; Factor VIII; Immunosuppression; Inhibitor

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; ANTIFIBRINOLYTIC AGENT; ANTITHROMBOCYTIC AGENT; AUTOANTIBODY; AZATHIOPRINE; BLOOD CLOTTING FACTOR 8; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DESMOPRESSIN; FIBRIN GLUE; HEMOSTATIC AGENT; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PREDNISOLONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RITUXIMAB; STEROID; VINCRISTINE; WARFARIN;

ACQUIRED HEMOPHILIA A; ADD ON THERAPY; ANTIBODY TITER; ARTERY THROMBOSIS; AUTOIMMUNE DISEASE; BLEEDING; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTINUOUS INFUSION; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG FATALITY; DRUG HALF LIFE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART INFARCTION; HEMOPHILIA A; HUMAN; IMMUNOADSORPTION; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTERNATIONAL NORMALIZED RATIO; LABORATORY DIAGNOSIS; MUCOSAL BLEEDING; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; PATHOPHYSIOLOGY; PLASMAPHERESIS; PREGNANCY; PRIORITY JOURNAL; PROPHYLAXIS; RELAPSE; REMISSION; REVIEW; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT RESPONSE; VEIN THROMBOSIS;

ADULT; CHILD; DEAMINO ARGININE VASOPRESSIN; FACTOR VIII; FEMALE; HEMOPHILIA A; HUMANS; IMMUNOGLOBULINS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; MALE; PREGNANCY; PREGNANCY COMPLICATIONS; RECURRENCE;

EID: 72649102353     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2009.07915.x     Document Type: Review

References (98)

1. Adedayo, A.A., Skorupa, A., Lal, A., Ronsih, E., Mercier, R.J. Islam, R. (2006) Rituximab in the treatment of acquired factor VIII inhibitors. Thrombosis and Haemostasis, 96, 84 87.
2. Aggarwal, A., Grewal, R., Green, R.J., Boggio, L., Green, D., Weksler, B.B., Wiestner, A. Schechter, G.P. (2006) Rituximab for autoimmune haemophilia: a proposed treatment algorithm. Haemophilia, 11, 13 19.
3. Aledort, L.M. (2004) Comparitive thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity. Journal of Thrombosis and Haemostasis, 2, 1700 1708.
4. Aledort, L.M. (2005) Comparitive thrombotic event incidence after infusion of recombinant factor VIIa vs factor VIII inhibitor bypass activity - reply to a rebuttal. Journal of Thrombosis and Haemostasis, 3, 822.
5. Algiman, M., Dietrich, G., Nydegger, U.E., Boieldieu, D., Sultan, Y. Kazatchkine, M.D. (1992) Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals. Proceedings of the National Academy of Sciences of the United States of America, 89, 3795 3799.
6. Au, W.Y., Lam, C.C. Kwong, Y.L. (2004) Successful treatment of acquired factor VIII inhibitor with cyclosporin. Haemophilia, 10, 98 100.
7. Bayer, R.L., Lichtman, S.M., Allen, S.L., Budman, D.R., Buchbinder, A., Fetten, J., Kolitz, J. Loscalzo, J. (1999) Acquired factor VIII inhibitors - successful treatment with an oral outpatient regimen. American Journal of Hematology, 60, 70 71.
8. Bossi, P., Cabane, J., Ninet, J., Dhote, R., Hanslik, T., Chosidow, O., Jouan-Flahault, C., Horellou, M.H., Leynadier, F., Liozon, E., Pouchot, J., Robin, J.P., Sanderson, F., Schaeffer, A., Sicard, D., Staikowsky, F., Wechsler, B. Zittoun, R. (1998) Acquired hemophilia due to factor VIII inhibitors in 34 patients. American Journal of Medicine, 105, 400 408. (Pubitemid 28536225)
9. Burnet, S.P., Duncan, E.M., Lloyd, J.V. Han, P. (2001) Acquired haemophilia in South Australia: a case series. Internal Medicine Journal, 31, 556 559.
10. Coller, B.S., Hultin, M.B., Hoyer, L.W., Miller, F., Dobbs, J.V., Dosik, M.H. Berger, E.R. (1981) Normal pregnancy in a patient with a prior postpartum factor VIII inhibitor: with observations on pathogenesis and prognosis. Blood, 58, 619 624.
11. Collins, P., Macartney, N., Davies, R., Lees, S., Giddings, J. Majer, R. (2004) A population based, unselected, consecutive cohort of patients with acquired haemophilia A. British Journal of Haematology, 124, 86 90.
12. Collins, P.W., Hirsch, S., Baglin, T.P., Dolan, G., Hanley, J., Makris, M., Keeling, D.M., Liesner, R., Brown, S.A. Hay, C.R.M. (2007) Acquired haemophilia A in the UK: a two year national surveillance study by UK Haemophilia Centre Doctors' Organisation. Blood, 109, 1870 1877.
13. Collins, P.W., Baudo, F., Huth-Kuhne, A., Knobl, P., Levesque, H., Marco, P., Nemes, L., Peerlinck, K. Tengborg, L. (2009) Firstline immunosuppressive treatment for acquired factor VIII antibodies: results of the European acquired haemophilia registry (EACH2). Journal of Thrombosis and Haemostasis, 7, Abstr Mo 609.
14. Dedeken, L., Louis, J., St. Demers, C., Meilleur, C. Rivard, G.E. (2009) Postpartum acquired haemophilia: a single centre experience with rituximab. Haemophilia, 15, 1166 1168.
15. Dehmel, H., Werwitzke, S., Trummer, A., Ganser, A. Tiede, A. (2008) Thrombelastographic monitoring of recombinant factor VIIa in acquired haemophilia. Haemophilia, 14, 736 742.
16. Delgado, J., Jimenez-Yuste, V., Hernandez-Navarro, F. Villar, A. (2003) Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factors. British Journal of Haematology, 121, 21 35.
17. Di Bona, E., Schiavoni, M., Castaman, G., Ciavarella, N. Rodeghiero, F. (2006) Acquired haemophilia: experience of two Italian centres with 17 new cases. Haemophilia, 3, 183 188.
18. Dragani, A., Febo, F., Pennese, E., Rolandi, G., Spadano, A. Davi, G. (2004) Acquired haemophilia masked by heparin therapy. International Journal of Immunopathology and Pharmacology, 17, 227 228.
19. Dykes, A.C., Walker, I.D., Lowe, G.D. Tait, R.C. (2001) Combined prednisolone and intravenous immunoglobulin treatment for acquired factor VIII inhibitors: a 2-year review. Haemophilia, 7, 160 163.
20. Ehrlich, H., Henzle, M.J. Gompers, E.D. (2002) Safety of factor VIII inhibitor bypassing activity (FEIBA): 10-year compilation of thrombotic events. Haemophilia, 8, 83 90.
21. Franchini, M. Lippi, G. (2008) Acquired factor VIII inhibitors. Blood, 112, 250 255.
22. Freedman, J., Rand, M.L., Russell, O., Davis, C., Cheatley, P.L., Blanchette, V. Garvey, M.B. (2003) Immunoadsorption may provide a cost-effective approach to management of patients with inhibitors to FVIII. Transfusion, 43, 1508 1513.
23. Garvey, B. (2008) Rituximab in the treatment of autoimmune haematological disorders. British Journal of Haematology, 141, 149 169.
24. Gawryl, M.S. Hoyer, L.W. (1982) Inactivation of factor VIII coagulant activity by two different types of human antibodies. Blood, 60, 1103 1109.
25. Godreuil, S., Navarro, R., Quittet, P., Landreau, L., Schved, J.F. Biron-Andreani, C. (2001) Acquired haemophilia in the elderly is a severe disease: report of five new cases. Haemophilia, 7, 428 432.
26. Green, D. (1998) Oral immunosuppressive therapy for acquired hemophilia. Annals of Internal Medicine, 128, 325.
27. Green, D. Lechner, K. (1981) A survey of 215 non-hemophilic patients with inhibitors to Factor VIII. Thrombosis & Haemostasis, 45, 200 203.
28. Green, D., Rademaker, A.W. Briet, E. (1993) A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. Thrombosis & Haemostasis, 70, 753 757.
29. Grunewald, M., Beneke, H., Guthner, C., Germowitz, A., Brommer, A. Griesshammer, M. (2001) Acquired haemophilia: experiences with a standardized approach. Haemophilia, 7, 164 169.
30. Guillet, B., Kriaa, F., Huysse, M.G., Proulle, V., George, C., Tchernia, G., D'Oiron, R., Laurian, Y., Charpentier, B., Lambert, T. Dreyfus, M. (2001) Protein A sepharose immunoadsorption: immunological and haemostatic effects in two cases of acquired haemophilia. British Journal of Haematology, 114, 837 844.
31. Haj, M., Dasani, H., Kundu, S., Mohite, U. Collins, P.W. (2004) Acquired haemophilia A may be associated with clopidogrel. BMJ, 329, 323.
32. Hart, H.C., Kraaijenhagen, R.J., Kerckhaert, J.A., Verdel, G., Freen, M. van deWiel, A. (1988) A patient with a spontaneous factor VIII:C autoantibody: successful treatment with cyclosporine. Transplantation Proceedings., 20, 323 328.
33. Hauser, I., Schneider, B. Lechner, K. (1995) Post-partum factor VIII inhibitors. A review of the literature with special reference to the value of steroid and immunosuppressive treatment. Thrombosis & Haemostasis, 73, 1 5.
34. Hay, C.R. (1998) Acquired haemophilia. Baillieres Clinical Haematology, 11, 287 303.
35. Hay, C.R., Lozier, J.N., Lee, C.A., Laffan, M., Tradati, F., Santagostino, E., Ciavarella, N., Schiavoni, M., Fukui, H., Yoshioka, A., Teitel, J., Mannucci, P.M. Kasper, C.K. (1996) Safety profile of porcine factor VIII and its use as hospital and home-therapy for patients with haemophilia-A and inhibitors: the results of an international survey. Thrombosis & Haemostasis, 75, 25 29.
36. Hay, C.R., Negrier, C. Ludlam, C.A. (1997) The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thrombosis & Haemostasis, 78, 1463 1467.
37. Hay, C.R., Baglin, T.P., Collins, P.W., Hill, F.G. Keeling, D.M. (2000) The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO). British Journal of Haematology, 111, 78 90.
38. Hay, C.R.M., Brown, S.A., Collins, P.W., Keeling, D.M. Liesner, R. (2006) The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. British Journal of Haematology, 133, 591 605.
39. Holme, P.A., Brosstad, F. Tjonnfjord, G.E. (2005) Acquired haemophilia: management of bleeds and immune therapy to eradicate autoantibodies. Haemophilia, 11, 510 515.
40. Huang, Y.W., Saidi, P. Philipp, C. (2004) Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases. Haemophilia, 10, 713 721.
41. Hultin, M.B., Shapiro, S.S., Bowman, H.S., Gill, F.M., Andrews, A.T., Martinez, J., Eyster, E.M. Sherwood, W.C. (1976) Immunosuppressive therapy of factor VIII inhibitors. Blood, 48, 95 108.
42. Huth-Kuhne, A., Baudo, F., Collins, P., Ingerslev, J., Kessler, C., Levesque, H., Castellano, M., Shima, M. St Louis, J. (2009) International recommendations on the diagnosis and treatment of patients with acquired haemophilia A. Haematologica, 94, 566 575.
43. Italian Association of Haemophilia Centres (AICE) (2006) Acquired factor VIII inhibitors in pregnancy: data from the Italian Haemophilia Registry relevant to clinical practice. International Journal of Obstetrics and Gynaecology, 110, 311 314.
44. Ji, L., Yang, R., Yang, D., Chen, Z., Xing, S., Tian, M. Sun, Y. (2006) Prednislone and low-dose activated prothrombin complex concentrates for FVIII inhibitor in nonhemophilic patients. Haemophilia, 4, 721 724.
45. Kain, S., Copeland, T.S. Leahy, M.F. (2002) Treatment of refractory autoimmune (acquired) haemophilia with anti-CD20 (rituximab). British Journal of Haematology, 119, 578.
46. Kazmi, M.A., Pickering, W., Smith, M.P., Holland, L.J. Savidge, G.F. (1998) Acquired haemophilia A: errors in the diagnosis. Blood Coagulation & Fibrinolysis, 9, 623 628.
47. Kessler, C. Asatiani, E. (2006) Acquired inhibitors to factor VIII. In : Textbook of Hemophilia (ed. by C.A. Lee, E. Berntorp W.K. Hoots pp. 86 90. Blackwells, Maassachusetts.
48. Lak, M., Sharifian, R.A., Karimi, K. Mansouritorghabeh, H. (2009) Acquired hemophilia A: clinical features, surgery and treatment of 34 cases, and experience of using recombinant factor VIIa. Clinical and Applied Thrombosis/Hemostasis, doi :.
49. Levesque, H., Tengborg, L., Marco, P., Baudo, F., Collins, P., Knobl, P., Huth-Kuhne, A. Nemes, L. (2009) Acquired haemophilia: descriptive data of the European acquired haemophilia registry (EACH2). Journal of Thrombosis and Haemostasis, 7, Abstr We 604.
50. Lian, E.C., Larcada, A.F. Chiu, A.Y. (1989) Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor. Annals of Internal Medicine, 110, 774 778.
51. Lian, E.C., Villar, M.J., Noy, L.I. Ruiz-Dayao, Z. (2002) Acquired factor VIII inhibitor treated with cyclophosphamide, vincristine, and prednisone. American Journal of Hematology, 69, 294 295.
52. Lottenberg, R., Kentro, T.B. Kitchens, C.S. (1987) Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy. Archives of Internal Medicine, 147, 1077 1081.
53. Lulla, R.R., Allen, G.A., Zakarija, A. Green, D. (2009) Transplacental transfer of postpartum inhibitors to factor VIII. Haemophilia, 15, 1166 1168.
54. Mahlangu, J., Andreeva, A.T., Macfarland, D., Reding, M.T., Walsh, C., Ritchie, B., Ewing, N., Kessler, C., Kempton, C., Libby, E., Zozulya, N., Shapiro, A.D., Louis, J., St. Warrier, I., Hoots, W.K., Gruppo, R. Mueksch, J. (2007) A phase II open-label study evaluating hemostatic activity, pharmacokinetics and safety of recombinant porcine factor VIII (OBI-1) in hemophilia A patients with alloantibody inhibitors directed against human FVIII. Blood (ASH Annual Meeting Abstracts), 110, Abstr 783.
55. Matsumoto, T., Shima, M., Fukuda, K., Nogami, K., Giddings, J.C., Murakami, T., Tanaka, I. Yoshioka, A. (2001) Immunological characterization of factor VIII autoantibodies in patients with acquired hemophilia A in the presence or absence of underlying disease. Thrombosis Research, 104, 381 388.
56. Mazzucconi, M.G., Bizzoni, L., Giorgi, A., Morano, S.G., Peraino, M., Russo, M. Alimena, G. (2001) Postpartum inhibitor to factor VIII: treatment with high-dose immunoglobulin and dexamethasone. Haemophilia, 7, 422 427.
57. Michiels, J.J., Hamulyak, K., Nieuwenhuis, H.K., Novakova, I. van Vliet, H.H. (1997) Acquired haemophilia A in women postpartum: management of bleeding episodes and natural history of the factor VIII inhibitor. European Journal of Haematology, 59, 105 109.
58. Moraca, R.J. Ragni, M.V. (2002) Acquired anti-FVIII inhibitors in children. Haemophilia, 8, 28 32.
59. Morrison, A.E. Ludlam, C.A. (1995) Acquired haemophilia and its management. British Journal of Haematology, 89, 231 236.
60. Morrison, A.E., Ludlam, C.A. Kessler, C. (1993) Use of porcine factor VIII in the treatment of patients with acquired hemophilia. Blood, 81, 1513 1520.
61. Mudad, R. Kane, W.H. (1993) DDAVP in acquired hemophilia A: case report and review of the literature. American Journal of Hematology, 43, 295 299.
62. Nemes, L. Pitlik, E. (2000) New protocol for immune tolerance induction in acquired hemophilia. Haematologica, 85 (Suppl. 10 64 68.
63. Ng, H.J., Tan, D.C. Lee, L.H. (2006) Treament and outcome of acquired haemophilia A with a standard conventional regimen in a cohort without associated conditions. Haemophilia, 12, 423 428.
64. O'Gorman, P., Dimichele, D.M., Kasper, C.K., Mannucci, P.M., Santagostini, E. Hay, C.R. (2001) Continuous infusion of porcine factor VIII in patients with haemophilia A and high-responding inhibitors: stability and clinical experience. Haemophilia, 7, 537 543.
65. Parameswaran, R., Shapiro, A.D., Gill, J.C., Kessler, C.M. for the HTRS Registry Investigators (2005) Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry. Haemophilia, 11, 100 106.
66. Pardos-Gea, J., Ordi-Ros, J., Altisent, C., Balada, E., Perez-Lopez, J. Vilardell, M. (2006) Acquired haemophilia A: successful treatment with immunosuppression, methylprednisolone pulses and oral cyclosporin. Thrombosis & Haemostasis, 95, 735 737.
67. Pavlova, A., Diaz-Lacava, A., Zeitler, H., Satoguina, J., Niemann, B., Krause, M., Scharrer, I., Hoerauf, A., Wienker, T. Oldenburg, J. (2008) Increased frequency of the CTLA-4 49 A/G polymorphism in patients with acquired haemophilia A compared to healthy controls. Haemophilia, 14, 355 360.
68. Pfliegler, G., Boda, Z., Harsfalvi, J., Flora-Nagy, M., Sari, B., Pecze, K. Rak, K. (1989) Cyclosporin treatment of a woman with acquired haemophilia due to factor VIII:C inhibitor. Postgraduate Medical Journal, 65, 400 402.
69. Reding, M.T., Lei, S., Lei, H., Green, D., Gill, J. Conti-Fine, B.M. (2002) Distribution of Th1- and Th2-induced anti-factor VIII IgG subclasses in congenital and acquired hemophilia patients. Thrombosis & Haemostasis, 88, 568 575.
70. Ries, M., Wolfel, D. Maier-Brandt, B. (1995) Severe intracranial hemorrhage in a newborn infant with transplacental transfer of an acquired factor VIII inhibitor. Journal of Pediatrics, 127, 649 650.
71. Rivard, G.E., St Louis, J., Lacroix, S., Champagne, M. Rock, G. (2003) Immunoadsorption for coagulation factor inhibitors: a retrospective critical appraisal of 10 consecutive cases from a single institution. Haemophilia, 9, 711 716.
72. Sahud, M.A., Pratt, K.P., Zhukov, O., Qu, K. Thompson, A.R. (2007) ELISA system for detection of immune responses to FVIII: a study of 246 samples and correlation with the Bethesda assay. Haemophilia, 13, 317 322.
73. Sallah, S. (2004) Treatment of acquired haemophilia with factor eight inhibitor bypassing activity. Haemophilia, 10, 169 173.
74. Sallah, S. Wan, J.Y. (2001) Inhibitors against factor VIII in patients with cancer. Analysis of 41 patients. Cancer, 91, 1067 1074. (Pubitemid 32295411)
75. Sallah, S., Singh, P. Hanrahan, L.R. (1998) Antibodies against factor VIII in patients with solid tumors: successful treatment of cancer may suppress inhibitor formation. Haemostasis, 28, 244 249.
76. Santagostino, E., Mancuso, M.E., Rocino, A., Mancuso, G., Scaraggi, F. Mannucci, P.M. (2006) A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors. Journal of Thrombosis and Haemostasis, 4, 367 371.
77. Saxena, R., Mishra, D.K., Kashyap, R., Choudhry, V.P., Mahapatra, M. Bhargava, M. (2000) Acquired haemophilia - a study of ten cases. Haemophilia, 6, 78 83.
78. Scandella, D., Mattingly, M., de Graaf, S. Fulcher, C.A. (1989) Localization of epitopes for human factor VIII inhibitor antibodies by immunoblotting and antibody neutralization. Blood, 74, 1618 1626.
79. Schulman, S., Langevitz, P., Livneh, A., Mortinowitz, U., Seligsohn, U. Varon, D. (1996) Cyclosporine therapy for acquired factor VIII inhibitor in a patient with systemic lupus erythematosus. Thrombosis & Haemostasis, 76, 344 346.
80. Schwartz, R.S., Gabriel, D.A., Aledort, L.M., Green, D. Kessler, C.M. (1995) A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin. Blood, 86, 797 804.
81. Shaffer, L.G. Phillips, M.D. (1997) Successful treatment of acquired hemophilia with oral immunosuppressive therapy. Annals of Internal Medicine, 127, 206 209.
82. Sohngen, D., Specker, C., Bach, D., Kuntz, B.M., Burk, M., Aul, C., Kobbe, G., Heyll, A., Hollmig, K.A. Schneider, W. (1997) Acquired factor VIII inhibitors in nonhemophilic patients. Annals of Hematology, 74, 89 93.
83. Solymoss, S. (1998) Postpartum acquired factor VIII inhibitors: results of a survey. American Journal of Hematology, 59, 1 4.
84. Sorensen, B. Ingerslev, J. (2004) Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. Journal of Thrombosis and Haemostasis, 2, 102 110.
85. Sorensen, B. Ingerslev, J. (2005) Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography. Haemophilia, 11 (Suppl. 1 1 6.
86. Spero, J.A., Lewis, J.H. Hasiba, U. (1981) Corticosteroid therapy for acquired F VIII:C inhibitors. British Journal of Haematology, 48, 635 642.
87. Stasi, R., Brunetti, M., Stipa, E. Amadori, S. (2004) Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia. Blood, 103, 4424 4428.
88. Sumner, M.J., Geldziler, B.D., Pedersen, M. Seremetis, S. (2007) Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal. Haemophilia, 13, 451 461.
89. Tiede, A., Eisert, R., Czwalinna, A., Miesbach, W., Scharrer, I., Ganser, A. von Depka, M. (2004) Acquired hemophilia caused by non-hemophilic factor VIII gene variants. Blood, 104, 3083.
90. Tjonnfjord, G.E. (2004) Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX: the updated Norwegian experience. Haemophili, 2 (Suppl. 10 41 45.
91. Turecek, P.L., Varadi, K., Keil, B., Negrier, C., Berntorp, E., Astermark, J., Bordet, J.C., Morfini, M., Linari, S. Schwarz, H.P. (2003) Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay. Pathophysiology of Haemostasis and Thrombosis, 33, 16 22.
92. Uggla, B., Linder, O. Schulman, S. (2003) Acquired hemophilia masked by warfarin therapy: report on two cases. Blood Coagulation & Fibrinolysis, 14, 769 772.
93. Vadikolia, C.M., Riddell, A., Brooks, S., Yee, T.T., Brown, S. Lee, C. (2007) Acquired haemophilia masked by warfarin therapy. International Journal of Laboratory Hematology, 29, 64 68.
94. Varadi, K., Negrier, C., Berntorp, E., Astermark, J., Bordet, J.C., Morfini, M., Linari, S., Schwarz, H.P. Turecek, P.L. (2003) Monitoring the bioavailability of FEIBA with a thrombin generation assay. Journal of Thrombosis and Haemostasis, 1, 2374 2380.
95. Wiestner, A., Cho, H.J., Asch, A.S., Michelis, M.A., Zeller, J.A., Peerschke, E.I., Weksler, B.B. Schechter, G.P. (2002) Rituximab in the treatment of acquired factor VIII inhibitors. Blood, 100, 3426 3428.
96. Wootla, B., Dasgupta, S., Dimitrov, J.D., Bayry, J., Levesque, H., Borg, J.Y., Borel-Derlon, A., Rao, D.N., Friboulet, A., Kaveri, S.V. Lacroix-Desmazes, S. (2008) Factor VIII hydrolysis mediated by anti-factor VIII autoantibodies in acquired hemophilia. Journal of Immunology, 180, 7714 7720.
97. Yee, T.T., Taher, A., Pasi, K.J. Lee, C.A. (2000) A survey of patients with acquired haemophilia in a haemophilia centre over a 28-year period. Clinical & Laboratory Haematology, 22, 275 278.
98. Zeitler, H., Ulrich-Merzenich, G., Hess, L., Konsek, E., Unkrig, C., Walger, P., Vetter, H. Brackmann, H.H. (2006) Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept. Blood, 105, 2287 2293.